A detailed history of Barclays PLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Barclays PLC holds 232,566 shares of NKTX stock, worth $546,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares
232,566
Previous 232,566 -0.0%
Holding current value
$546,530
Previous $1.05 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$4.52 - $8.0 $649,108 - $1.15 Million
143,608 Added 161.43%
232,566 $1.05 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $262,614 - $539,182
49,832 Added 127.36%
88,958 $526,000
Q1 2024

May 15, 2024

SELL
$5.59 - $15.71 $234,852 - $660,024
-42,013 Reduced 51.78%
39,126 $423,000
Q4 2023

Feb 15, 2024

BUY
$1.31 - $6.6 $47,156 - $237,580
35,997 Added 79.74%
81,139 $537,000
Q3 2023

Nov 07, 2023

SELL
$1.39 - $2.29 $461,769 - $760,756
-332,208 Reduced 88.04%
45,142 $63,000
Q2 2023

Aug 03, 2023

SELL
$2.19 - $5.17 $38,756 - $91,493
-17,697 Reduced 4.48%
377,350 $827,000
Q1 2023

May 04, 2023

BUY
$3.37 - $6.3 $26,205 - $48,988
7,776 Added 2.01%
395,047 $1.4 Million
Q4 2022

Feb 13, 2023

SELL
$5.14 - $14.35 $341,296 - $952,840
-66,400 Reduced 14.64%
387,271 $2.32 Million
Q3 2022

Nov 03, 2022

BUY
$12.27 - $18.39 $1.31 Million - $1.96 Million
106,775 Added 30.78%
453,671 $5.97 Million
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $2.66 Million - $6.66 Million
342,666 Added 8100.85%
346,896 $4.27 Million
Q1 2022

May 16, 2022

BUY
$8.66 - $14.99 $36,631 - $63,407
4,230 New
4,230 $48,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.